Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CREST-I: Reserpine, Gabapentin, or Lamotrigine vs. Placebo
NCT00015106Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Nov 1997
- Primary completion
- Jan 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of reserpine, gabapentin and lamotrigine in cocaine dependence (4 arms), sponsored by National Institute on Drug Abuse. Primary endpoints: Urine toxicology for cocaine, Adverse events and 1 more. Started Nov 1997; status: completed.
02
Drugs
reserpinegabapentinlamotrigine
03
Conditions
cocaine dependence
Beyond the preview
Go deeper on NCT00015106.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00015106.